Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

Interview
Spotlight Article

Where will synthetic biology take cell & gene therapy?

2020 vision - Tools and Technologies of Tomorrow

Tim Lu

Tim Lu is a pioneer in synthetic biology and an Associate Professor at MIT. He received his MD/PhD from MIT and Harvard. He is a co-founder of Synlogic (NASDAQ: SYBX), Tango Therapeutics, Sample6, Eligo, BiomX, and Engine Biosciences. He has received the NIH New Innovator Award, the US President Early Career Award for Scientists and Engineers, MIT Technology Review’s TR35, Navy and Army Young Investigator Prizes, and others.

DOI: 10.18609/cgti.2019.160
Citation: Cell & Gene Therapy Insights 2019; 5(12), 1549-1555.
Open access
This content is restricted to registered users. Click here to Register or Login here.
Twitter IconVisit Our Blog